Tormere Analytics
OverviewStock ResearchChartsPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Articles
Pricing
Privacy PolicyTerms of Service

CAI

$28.30-0.18%website ↗⬇ financials (.py)

Caris Life Sciences, Inc.

Market Cap
$8.0B
Live price × shares (2026-09-16)
Sector
Health Care
Industry
Biotechnology
Beta (raw)
—
Insufficient price history
P/E (TTM)
76.1
Price / TTM net income
P/S (TTM)
8.1
Price / TTM revenue
P/B
13.5
Price / stockholders equity
EV/EBITDA
43.5
TTM
Price Chart
Loading…

Signals

Insider Velocity
112.7x
selling
Congress
—
recent trades
Short Volume
53%
W/W +18.7pp

Market & Alt Data

News
15
recent articles
Activist
—
none active
Analyst Consensus
Strong Buy
16 analysts
Velocity Score
112.69x
Sell Rate (90d)
11163.47/mo
Sell Baseline
254.08/mo
Unique Sellers (90d)
3
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-09-222026-09-23Denton John RusselSee RemarksSale7,500$31.82$239K174.9KView
2026-09-172026-09-17Brille Brian JDirector & See RemarksSale400.0K$30.33$12.13M230.3KView
2026-09-042026-09-04Spetzler David BaxleyPresidentSale119.2K$24.76$2.95M1.18MView
2026-09-032026-09-04Spetzler David BaxleyPresidentSale478.0K$24.86$11.88M1.05MView
2026-05-152026-07-13HALBERT JONDirectorPurchase68.0K$14.56$990K704.6KView
1–5 of 11
1 / 3

Reporting Insiders

  • John Russel Denton
    See Remarks
    1 transaction · last 2026-09-22
  • Brian J. Brille
    Director & See Remarks
    1 transaction · last 2026-09-17
  • David Baxley Spetzler
    President
    3 transactions · last 2026-09-04
  • Jon Halbert
    Director
    1 transaction · last 2026-05-15
  • Jeff L. Vacirca
    Director
    1 transaction · last 2026-05-11
  • Luke Thomas Power
    See Remarks
    2 transactions · last 2025-12-11
  • David Baxley Spetzler
    President
    1 transaction · last 2025-11-07

Recent News

IPO Stock Of The Week: Caris Pulls Back After More Than Doubling In Just Two Months
Yahoo · 2026-10-02
Caris Life Sciences Unveils the Next Evolution of Liquid Biopsy with Enhanced Caris Assure
Yahoo · 2026-09-29
Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress
SeekingAlpha · 2026-09-29
Caris Life Sciences Coasts Past A Buy Point; Why This Texas Biotech Researcher Deserves A Look
Yahoo · 2026-09-22
Caris Life Sciences: Adjusting My Position After A Recent Steep Incline (Downgrade)
SeekingAlpha · 2026-09-22
Are Medical Stocks Lagging Bristol Myers Squibb (BMY) This Year?
Yahoo · 2026-09-18
Caris Life Sciences Stock Jumped 10% Yesterday. Here’s Where Shares Could Go Further in 2026.
Yahoo · 2026-09-18
Caris Life Sciences: Diagnostics Growth With Room To Run
SeekingAlpha · 2026-09-17
Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division
Yahoo · 2026-09-16
Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength?
Yahoo · 2026-09-16
Caris Life Sciences, Inc. (CAI) Soars 9.4%: Is Further Upside Left in the Stock?
Yahoo · 2026-09-16
10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today
Benzinga · 2026-09-15
Could Caris Life Sciences (CAI) Be 7% Undervalued After Its Lung Cancer Research Update?
Yahoo Finance · 2026-09-06
Caris Life Sciences (CAI) Will Present Seven Studies At A Global Lung Conference
Yahoo Finance · 2026-09-05
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
Yahoo Finance · 2026-09-02

Informational purposes only, not investment advice.

Caris Life Sciences, Inc. (CAI)

tormere.com/research/CAI · generated 2026-10-04

$28.30
-0.18%
General Information
Price$28.30
Change-0.18%
Market Cap$8.0B
SectorHealth Care
IndustryBiotechnology
ExchangeNasdaq
Beta (raw, monthly vs SPY)—
Signals
Insider Velocity112.7x selling
Congress Trades—
  • John Russel Denton
    See Remarks
    2 transactions · last 2025-11-07
  • Brian J. Brille
    Director & See Remarks
    1 transaction · last 2025-06-20
  • Short Volume
    53% of daily vol
    Conviction Score21/100
    Analyst ConsensusSB 6 · B 6 · H 4 · S 0 · SS 0
    Price Chart (1 Year)
    2025-10-062026-10-02$32.95$14.55
    Recent Insider Activity (Form 4) — Last 5
    DateInsiderTypeSharesValue
    2026-09-22Denton John RusselS7,500$238,626
    2026-09-17Brille Brian JS400,000$12M
    2026-09-04Spetzler David BaxleyS119,212$3M
    2026-09-03Spetzler David BaxleyS84,900$2M
    2026-09-03Spetzler David BaxleyS393,100$10M
    Recent News
    • IPO Stock Of The Week: Caris Pulls Back After More Than Doubling In Just Two Months — Yahoo · 2026-10-02
    • Caris Life Sciences Unveils the Next Evolution of Liquid Biopsy with Enhanced Caris Assure — Yahoo · 2026-09-29
    • Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress — SeekingAlpha · 2026-09-29
    • Caris Life Sciences Coasts Past A Buy Point; Why This Texas Biotech Researcher Deserves A Look — Yahoo · 2026-09-22
    • Caris Life Sciences: Adjusting My Position After A Recent Steep Incline (Downgrade) — SeekingAlpha · 2026-09-22

    Tormere — informational purposes only, not investment advice.

    Factor Profile

    Pro
    Pro feature

    Fama-French factor analysis is available on the Pro plan.

    Upgrade to Pro →